ANUH PHARMA LIMITED (ANUHPHR) financials

ANUH PHARMA LIMITED (ANUHPHR) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1960, Anuh Pharma Ltd is in the business of manufacturing and selling of Bulk drugs and chemicals[1]

Market Cap: ₹830Cr.
Current Price: ₹82.8
Stock P/E: 18.8
ROE: 10.7%
ROCE: 14.9%
Book Value: ₹35.1
Dividend Yield: 1.81%
52W High / Low: ₹99.5/66.7

In Jun 2026, ANUH PHARMA LIMITED (ANUHPHR) reported sales ₹194 Cr and net profit ₹11 Cr.

Annual TTM: sales ₹779 Cr, net profit ₹44 Cr.

Shareholding: Promoters 71.79% (Sep 2026), FIIs 0.11% (Sep 2026), DIIs 0.00% (Sep 2026), Public 28.07% (Sep 2026), No. of Shareholders 28,447% (Sep 2026).

ANUHPHR quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	166	160	198	186	186	197	202	194
Expenses	149	145	179	176	174	178	182	178
Operating Profit	17	15	19	10	12	19	20	16
OPM %	10%	9%	9%	6%	6%	10%	10%	8%
Other Income	3	1	1	3	1	2	-1	3
Interest	0	0	0	0	0	0	0	0
Depreciation	2	2	3	3	3	3	3	2
Profit before tax	18	13	17	11	10	18	16	17
Tax %	17%	22%	28%	24%	23%	25%	25%	32%
Net Profit	15	10	12	8	8	13	12	11
EPS in Rs	1.50	1.03	1.24	0.83	0.76	1.34	1.17	1.14
Raw PDF	—	—	—	—	—	—	—	—

ANUHPHR profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	307	432	487	527	647	662	772	779
Expenses	284	387	439	476	571	600	709	712
Operating Profit	23	45	47	52	76	62	62	67
OPM %	8%	10%	10%	10%	12%	9%	8%	9%
Other Income	4	11	5	6	12	9	4	5
Interest	1	2	2	1	1	1	1	0
Depreciation	7	15	12	10	9	9	11	11
Profit before tax	19	39	39	47	78	61	54	60
Tax %	25%	26%	22%	24%	23%	22%	24%	—
Net Profit	14	28	31	36	60	47	41	44
EPS in Rs	1.43	2.84	3.05	3.61	5.99	4.73	4.10	4.41
Dividend Payout %	48%	26%	29%	28%	21%	16%	37%	—

ANUHPHR balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	13	13	25	25	25	25	25	50
Reserves	152	150	166	189	216	266	301	302
Borrowings	4	45	14	4	1	3	11	0
Other Liabilities	71	119	128	129	163	152	170	205
Total Liabilities	240	326	333	347	405	446	507	557
Fixed Assets	21	84	71	61	53	49	58	57
CWIP	34	0	0	0	0	0	0	0
Investments	39	80	31	43	91	97	106	84
Other Assets	147	163	230	243	261	300	342	416
Total Assets	240	326	333	347	405	446	507	557

ANUHPHR cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	7	49	-19	29	54	13	37	-3
Cash from Investing Activity	3	-77	52	-8	-43	1	-20	18
Cash from Financing Activity	-7	22	-33	-19	-12	-9	-5	-26
Net Cash Flow	3	-5	0	2	-2	5	12	-12
Free Cash Flow	-22	13	-25	27	52	8	17	-11
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	56%	232%	-20%	80%	130%	42%	78%	16%

ANUHPHR shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	69.91%	69.91%	69.91%	71.81%	71.81%	71.79%	71.79%	71.79%
FIIs	0.02%	0.04%	0.04%	0.00%	0.00%	0.05%	0.01%	0.11%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	30.07%	30.04%	30.04%	28.19%	28.17%	28.14%	28.19%	28.07%
No. of Shareholders	24,279	24,235	24,257	28,250	27,889	27,425	27,484	28,447

ANUHPHR key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	85	96	90	102	118	107	119	113
Inventory Days	64	98	90	77	66	57	54	90
Days Payable	89	166	133	117	139	105	115	114
Cash Conversion Cycle	61	28	48	62	46	58	59	89
Working Capital Days	65	-10	57	68	61	69	68	92
ROCE %	19%	10%	16%	18%	19%	26%	17%	15%

ANUHPHRUpdated 20 Oct 2026, 15:57

Anuh Pharma Limited

ANUHPHRUpdated 20 Oct 2026, 15:57

Market Cap

₹830Cr.

Current Price

₹82.8

High / Low

₹99.5/66.7

Stock P/E

18.8

ROE10.7%

ROCE14.9%

Book Value₹35.1

Face Value₹5.00

Dividend Yield1.81%

About

Incorporated in 1960, Anuh Pharma Ltd is in the business of manufacturing and selling of Bulk drugs and chemicals[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	161	148	3	2	15	24	12	1.17
Sep 2023	150	132	2	2	18	23	14	1.38
Dec 2023	172	148	4	2	25	24	19	1.91
Mar 2024	164	145	3	2	20	22	15	1.53
Jun 2024	138	127	4	2	12	22	10	0.95
Sep 2024	166	149	3	2	18	17	15	1.5
Dec 2024	160	145	1	2	13	22	10	1.03
Mar 2025	198	179	1	3	17	28	12	1.24
Jun 2025	186	176	3	3	11	24	8	0.83
Sep 2025	186	174	1	3	10	23	8	0.76
Dec 2025	197	178	2	3	18	25	13	1.34
Mar 2026	202	182	-1	3	16	25	12	1.17
Jun 2026	194	178	3	2	17	32	11	1.14

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	284	1	253	5	3	32	31	22	2.19
Mar 2016	326	1	289	4	2	38	32	26	2.57
Mar 2017	206	1	183	8	2	28	27	20	2
Mar 2018	238	0	220	7	2	23	29	17	1.65
Mar 2019	321	1	291	5	2	32	28	23	2.33
Mar 2020	307	1	284	4	7	19	25	14	1.43
Mar 2021	432	2	387	11	15	39	26	28	2.84
Mar 2022	487	2	439	5	12	39	22	31	3.05
Mar 2023	527	1	476	6	10	47	24	36	3.61
Mar 2024	647	1	571	12	9	78	23	60	5.99
Mar 2025	662	1	600	9	9	61	22	47	4.73
Mar 2026	772	1	709	4	11	54	24	41	4.1
TTM	779	0	712	5	11	60	—	44	4.41

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	71.79%
FIIs	0.11%
Public	28.07%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	69.94%	0%	0%	30.05%
Mar 2024	69.91%	0.03%	0.1%	29.96%
Jun 2024	69.91%	0.03%	0%	30.05%
Sep 2024	69.91%	0.02%	0%	30.06%
Dec 2024	69.91%	0.02%	0%	30.07%
Mar 2025	69.91%	0.04%	0%	30.04%
Jun 2025	69.91%	0.04%	0%	30.04%
Sep 2025	71.81%	0%	0%	28.19%
Dec 2025	71.81%	0%	0%	28.17%
Mar 2026	71.79%	0.05%	0%	28.14%
Jun 2026	71.79%	0.01%	0%	28.19%
Sep 2026	71.79%	0.11%	0%	28.07%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	4	97	0	67	168	9	0	43	116	168
Mar 2016	13	107	2	71	193	18	0	43	131	193
Mar 2017	13	128	0	48	189	17	0	70	101	189
Mar 2018	13	137	2	57	209	17	6	66	120	209
Mar 2019	13	152	4	71	240	21	34	39	147	240
Mar 2020	13	150	45	119	326	84	0	80	163	326
Mar 2021	25	166	14	128	333	71	0	31	230	333
Mar 2022	25	189	4	129	347	61	0	43	243	347
Mar 2023	25	216	1	163	405	53	0	91	261	405
Mar 2024	25	266	3	152	446	49	0	97	300	446
Mar 2025	25	301	11	170	507	58	0	106	342	507
Mar 2026	50	302	0	205	557	57	0	84	416	557

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	19	-12	-8	-1
Mar 2016	16	-5	-9	2
Mar 2017	26	-20	-4	2
Mar 2018	2	2	-5	-1
Mar 2019	7	3	-7	3
Mar 2020	49	-77	22	-5
Mar 2021	-19	52	-33	0
Mar 2022	29	-8	-19	2
Mar 2023	54	-43	-12	-2
Mar 2024	13	1	-9	5
Mar 2025	37	-20	-5	12
Mar 2026	-3	18	-26	-12

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	88	84	100	109	85	96	90	102	118	107	119	113
Inventory Days	27	35	72	64	64	98	90	77	66	57	54	90
Days Payable	79	77	102	105	89	166	133	117	139	105	115	114
Cash Conversion Cycle	36	42	70	68	61	28	48	62	46	58	59	89
Working Capital Days	43	48	79	80	65	-10	57	68	61	69	68	92
ROCE %	33%	35%	19%	14%	19%	10%	16%	18%	19%	26%	17%	15%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of ANUH PHARMA LIMITED (ANUHPHR)?

The reported market capitalisation for ANUH PHARMA LIMITED (ANUHPHR) is ₹830Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of ANUHPHR?

The current price shown for ANUH PHARMA LIMITED (ANUHPHR) on Fincrux is ₹82.8 with a 52-week high/low of ₹99.5/66.7.

What is the P/E ratio of ANUH PHARMA LIMITED (ANUHPHR)?

The stock P/E for ANUH PHARMA LIMITED (ANUHPHR) is 18.8 on Fincrux, with ROE at 10.7% and ROCE at 14.9%.

What were ANUHPHR latest quarterly results?

For Jun 2026, ANUH PHARMA LIMITED (ANUHPHR) reported sales ₹194 Cr and net profit ₹11 Cr (figures in ₹ crore unless noted).

What are ANUHPHR annual sales and net profit?

For TTM, ANUH PHARMA LIMITED (ANUHPHR) shows sales of ₹779 Cr and net profit of ₹44 Cr on the Fincrux profit & loss statement.

Who owns ANUH PHARMA LIMITED (ANUHPHR)?

Latest shareholding for ANUH PHARMA LIMITED (ANUHPHR) on Fincrux: Promoters 71.79% (Sep 2026), FIIs 0.11% (Sep 2026), DIIs 0.00% (Sep 2026), Public 28.07% (Sep 2026), No. of Shareholders 28,447% (Sep 2026).

Where can I find ANUH PHARMA LIMITED (ANUHPHR) financials?

ANUH PHARMA LIMITED (ANUHPHR) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show ANUHPHR balance sheet and cash flow?

Yes. The ANUH PHARMA LIMITED (ANUHPHR) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 20 October 2026 at 15:57